Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piyanuch Kongtim

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Haematology|April 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice changeBenjamin J Lee, Piyanuch Kongtim, Jean Doh, et al.
American Journal of Hematology|February 16, 2023
Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemiaBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2020
Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-Transplant Survival Prediction in Patients with Hematologic MalignanciesStefan O Ciurea, Piyanuch Kongtim, Omar Hasan, et al.
Cancer Treatment and Research Communications|January 7, 2026
Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell CarcinomaOmid Yazdanpanah, Aditya Mahadevan, David J Benjamin, et al.
American Journal of Hematology|September 3, 2022
CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switchBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
American Journal of Hematology|January 8, 2025
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell TransplantationPiyanuch Kongtim, Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, et al.
Transplantation and Cellular Therapy|May 6, 2024
Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 InfectionBenjamin J Lee, Pongthep Vittayawacharin, Shawn P Griffin, et al.
Haematologica|July 11, 2024
Extending duration of letermovir prophylaxis in haploidentical stem cell transplantationPongthep Vittayawacharin, Benjamin J Lee, Shawn Griffin, et al.
Blood Advances|July 30, 2020
Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantationJun Zou, Stefan O Ciurea, Piyanuch Kongtim, et al.
European Journal of Haematology|June 29, 2023
Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosisBenjamin J Lee, Yen Cao, Pongthep Vittayawacharin, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Haematology|April 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice changeBenjamin J Lee, Piyanuch Kongtim, Jean Doh, et al.
American Journal of Hematology|February 16, 2023
Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemiaBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2020
Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-Transplant Survival Prediction in Patients with Hematologic MalignanciesStefan O Ciurea, Piyanuch Kongtim, Omar Hasan, et al.
Cancer Treatment and Research Communications|January 7, 2026
Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell CarcinomaOmid Yazdanpanah, Aditya Mahadevan, David J Benjamin, et al.
American Journal of Hematology|September 3, 2022
CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switchBenjamin J Lee, Shawn P Griffin, Jean Doh, et al.
American Journal of Hematology|January 8, 2025
Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell TransplantationPiyanuch Kongtim, Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, et al.
Transplantation and Cellular Therapy|May 6, 2024
Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 InfectionBenjamin J Lee, Pongthep Vittayawacharin, Shawn P Griffin, et al.
Haematologica|July 11, 2024
Extending duration of letermovir prophylaxis in haploidentical stem cell transplantationPongthep Vittayawacharin, Benjamin J Lee, Shawn Griffin, et al.
Blood Advances|July 30, 2020
Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantationJun Zou, Stefan O Ciurea, Piyanuch Kongtim, et al.
European Journal of Haematology|June 29, 2023
Anakinra versus etoposide-based therapy added to high-dose steroids for the treatment of secondary hemophagocytic lymphohistiocytosisBenjamin J Lee, Yen Cao, Pongthep Vittayawacharin, et al.
Pageof 7